REGN
NASDAQStockRegeneron Pharmaceuticals, Inc.
$750.03-24.29 (-3.13%)
52-Week Range
$483.07
$812.27
Key Stats
Market Cap
77.9B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.40
Volume
377.8K
Avg Volume
633.8K
Performance
1M
-1.10%
3M
+0.72%
6M
+30.39%
YTD
-3.83%
1Y
+8.28%
3Y
-2.63%
5Y
+54.28%
Price Chart
ETF Exposure
REGN is held by 381 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MNTL | Tema Neuroscience And Mental Health ETF | 8.09% |
| BBH | VanEck Biotech ETF | 7.59% |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 6.92% |
| IBB | iShares Biotechnology ETF | 6.80% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 6.06% |
| PBE | Invesco Biotechnology & Genome ETF | 5.25% |
| KONG | Formidable Fortress ETF | 4.57% |
| QQQA | ProShares - Nasdaq-100 Dorsey Wright Momentum ETF | 4.56% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 4.12% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.90% |
| APXH | Two Roads Shared Trust - APEX HealthCare ETF | 3.83% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 3.80% |
| TBXU | Direxion Daily Biotech Top 5 Bull 2X ETF | 3.78% |
| LNGR | Global X Aging Population ETF | 3.52% |
| PINK | Simplify Health Care ETF | 3.50% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.46% |
| CNCR | Loncar Cancer Immunotherapy ETF | 3.36% |
| AGNG | Global X - Aging Population ETF | 3.18% |
| OZEM | Roundhill Investments - GLP-1 & Weight Loss ETF | 3.09% |
| PJP | Invesco Pharmaceuticals ETF | 2.90% |
| LSGR | Natixis Loomis Sayles Focused Growth ETF | 2.78% |
| MEDX | Horizon Kinetics Medical ETF | 2.74% |
| STNC | Hennessy Sustainable ETF | 2.69% |
| HELX | Franklin Genomic Advancements ETF | 2.57% |
| SGLC | SGI U.S. Large Cap Core ETF | 2.42% |
| JDOC | JPMorgan Healthcare Leaders ETF | 2.33% |
| QQEW | First Trust Nasdaq-100 Select Equal Weight ETF | 2.20% |
| COWG | Pacer US Large Cap Cash Cows Growth Leaders ETF | 2.18% |
| DEF | Invesco Defensive Equity ETF | 2.16% |
| POWA | Invesco Bloomberg Pricing Power ETF | 2.16% |
| USRD | Themes US R&D Champions ETF | 2.11% |
| INVN | Alger Russell Innovation ETF | 2.09% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 2.07% |
| FDG | American Century Focused Dynamic Growth ETF | 2.01% |
| SDG | iShares MSCI Global Sustainable Development Goals ETF | 1.92% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 1.88% |
| FXH | First Trust Health Care AlphaDEX Fund | 1.83% |
| QNXT | iShares Nasdaq-100 ex Top 30 ETF | 1.83% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 1.79% |
| RYH | Invesco S&P 500 Equal Weight Health Care ETF | 1.79% |
| QQXT | First Trust NASDAQ-100 Ex-Technology Sector Index Fund | 1.77% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 1.74% |
| ENTR | L&G Energy Transition Commodities UCITS ETF | 1.70% |
| PVAL | Putnam Focused Large Cap Value ETF | 1.67% |
| BBP | Virtus Biotech ETF | 1.59% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 1.55% |
| USCF | Themes US Cash Flow Champions ETF | 1.55% |
| FMIL | Fidelity Covington Trust - Fidelity Fundamental Large Cap Core ETF | 1.53% |
| QQQG | Pacer Nasdaq-100 Top 50 Cash Cows Growth Leaders ETF | 1.47% |
| PWV | Invesco Large Cap Value ETF | 1.46% |
Page 1 of 8Next
About REGN ETF Exposure
Regeneron Pharmaceuticals, Inc. (REGN) is held by 381 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 77.9B, REGN is a widely held institutional stock. The stock currently trades at $750.03. Investors can gain exposure to REGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold REGN, sorted by portfolio weight.